Kyverna Therapeutics, Inc. KYTX Debt-to-equity

Debt-to-equity at other companies

Bristol-Myers SquibbBMY

1.9×-0.9×

Gilead SciencesGILD

2.2×+1.0×

Climb Bio, Inc.CLYM

0×0.0×

Artiva Biotherapeutics, Inc.ARTV

0×-0.1×

Iovance Biotherapeutics, Inc.IOVA

0.1×0.0×

Allogene TherapeuticsALLO

0.3×+0.1×

FAQ

What is Kyverna Therapeutics, Inc.'s debt-to-equity?

Kyverna Therapeutics, Inc. (KYTX) reported debt-to-equity of 0× in Q1 2026.

How has Kyverna Therapeutics, Inc.'s debt-to-equity changed year-over-year?

Kyverna Therapeutics, Inc.'s debt-to-equity increased by 51.3% year-over-year, from 0× to 0×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.